You have to be signed in to use this resource.
Improving PPI Prescribing practices in line with ESC guidelines for patients with ACS on DAPT protocol promoting Patient Safety
European Society of Cardiology (ESC) guidelines recommend prescribing proton pump inhibitors (PPIs) in patients treated with DAPT, to mitigate their risk of bleeding complications. Prescribing PPIs in patients diagnosed with ACS on DAPT is strongly recommended by ESC. We have noted that it is not uncommon for PPIs to be missed and not prescribed in such circumstances. Leaving PPIs out of the treatment regimen in ACS on DAPT can increase risk of bleeding and increase risk of noncompliance to critical medications for the heart due to side-effects.
This resource provides data and techniques to tackle this issue and demonstrates sustainability.
Additional information
A quality improvement project undertaken in Aug/Sept 2024.
Resource details
| Contributed by: | WE-R NHS (Workforce and Education Research NHS) |
| Authored by: |
|
| Authored on: | 1 September 2024 |
| Licence: | Creative commons: Attribution-NonCommercial 4.0 International More information on licences |
| First contributed: | 19 November 2024 |
| Audience access level: | General user |
Share this resource
Report an issue with this resource
You may report a resource, for example, if there is an issue with copyright infringement, breach of personal data, factual inaccuracies, typing errors or safety concerns. The type of issue will determine whether the resource is immediately removed from the platform or if the contributor is asked to make amendments. You can report a resource from the resource information page or by contacting the Learning Hub support team.
You can contact the Learning Hub support team by completing the support form or if you have a general enquiry you can email enquiries@learninghub.nhs.uk.